Originally published In Press as doi:10.1074/jbc.M103720200 on June 26, 2001
J. Biol. Chem., Vol. 276, Issue 34, 31535-31541, August 24, 2001
Mechanistic Basis for Kinetic Differences between the
Rat
1,
2, and
3 Isoforms of the Na,K-ATPase*
Laura
Segall,
Stewart E.
Daly, and
Rhoda
Blostein
From the Department of Biochemistry and Medicine, McGill
University, Montreal, Quebec H3G 1A4, Canada
Received for publication, April 25, 2001, and in revised form, June 14, 2001
 |
ABSTRACT |
Previous studies showed that the
1,
2, and
3 isoforms of the catalytic subunit of the Na,K-ATPase differ in
their apparent affinities for the ligands ATP, Na+,
and K+. For the rat isoforms transfected into HeLa cells,
K'ATP for ATP binding at its low affinity site
is lower for
2 and
3 compared with
1; relative to
1 and
2,
3 has a higher K'Na and lower K'K (Jewell, E. A., and Lingrel,
J. B (1991) J. Biol. Chem. 266, 16925-16930;
Munzer, J. S., Daly, S. E., Jewell-Motz, E. A., Lingrel, J. B, and Blostein, R. (1994) J. Biol.
Chem. 269, 16668-16676). The experiments described in the
present study provide insight into the mechanistic basis for these
differences. The results show that
2 differs from
1 primarily by
a shift in the E1
E2 equilibrium in favor of
E1 form(s) as evidenced by (i) a ~20-fold increase in IC50 for vanadate, (ii) decreased catalytic
turnover, and (iii) notable stability of Na,K-ATPase activity at acidic pH. In contrast, despite its lower K'ATP
compared with
1, the E1
E2 poise of
3 is not shifted toward
E1. Distinct intrinsic interactions with
Na+ ions are underscored by the marked selectivity for
Na+ over Li+ of
3 compared with either
1
or
2 and higher K'Na for cytoplasmic Na+, which persists over a 100-fold range in proton
concentration, independent of the presence of K+. The
kinetic analysis also suggests
3-specific differences in relative
rates of partial reactions, which impact this isoform's distinct
apparent affinities for both Na+ and K+.
 |
INTRODUCTION |
The Na,K-ATPase or sodium pump is an integral membrane protein
complex that couples the exchange of three intracellular
Na+ ions for two extracellular K+ ions to the
hydrolysis of one molecule of ATP. The sodium pump is essential to the
maintenance of the electrochemical gradients of Na+ and
K+ across the plasma membrane of virtually all animal cells
and consequently provides the driving force for the transport of
nutrients such as glucose and amino acids into the cell. This enzyme is a P-type ATPase transporter and, as such, is directly phosphorylated on
a conserved aspartate residue within its cytoplasmic domain. Both the
phosphorylated and dephosphorylated forms of the enzyme exist in at
least two states that undergo conformational transitions (E1P
E2P and
E2
E1) that are
coupled to the ion-translocating steps.
The Na,K-ATPase comprises two essential subunits: a large catalytic
subunit (~110 kDa), containing the phosphorylation site as well as
the binding sites for Na+, K+, ATP and for the
cardiac glycoside ouabain, and a smaller, highly glycosylated
subunit (~35-55 kDa) that ensures the proper folding and delivery of
the
subunit to the plasma membrane, possibly also modulating cation
affinity (1, 2). A third subunit,
(~7 kDa), was found in the
kidney (3), where it functions as a regulator of the pump (for a
review, see Ref. 4). Several isoforms of
and
have been
described. In the case of
, there are four known isoforms that are
expressed in a tissue- and development-specific manner. In the rat,
they are distributed as follows.
1 is the ubiquitous,
"housekeeping" isoform;
2 is expressed in muscle, nerves, and
adult heart;
3 is present in nerves, brain, and fetal heart; and
recently the protein for
4 was found in rat testis, where it may participate in spermatogenesis and sperm motility (5, 6).
For a comprehensive review on Na,K-ATPase isozyme structure and
diversity in function, see Ref. 7.
Both our laboratory and others have compared the functional properties
of the
1,
2*, and
3* isoforms of the rat Na,K-ATPase within
the same mammalian membrane environment following transfection of their
cDNAs into HeLa cells. (
2* and
3* are the rat
2 and
3
isoforms rendered relatively resistant to ouabain, to permit their
distinction from endogenous ouabain sensitive enzyme (8).) The results
showed that the isozymes exhibit differences in their apparent ligand
affinities (see Table I). Both
2* and
3* have a 3-fold higher
apparent affinity for ATP binding (low affinity site) compared with the
1 isoform (K'ATP values of 120 and 130 µM, respectively, compared with 331 µM)
(9). In addition, while
1 and
2* show similar apparent affinities
for Na+ and K+, measurements both in broken
membranes and in intact cells revealed a lower apparent affinity of
3* for intracellular Na+ and a higher apparent affinity
for extracellular K+ (9, 10).
The present study investigates whether the aforementioned differences
in apparent affinities for ligands are the consequence of primary
differences in ligand interactions or whether and to what extent they
reflect differences in the E1
E2 conformational equilibrium. The results of
the present study, together with our earlier work (11), show that the
kinetic differences of the
2* isoform are a consequence of a shift
in the poise of the conformational equilibrium toward the
E1 form of the enzyme. In the case of
3*, the
mechanistic basis for the observed differences in ligand binding is
less straightforward. The notable differences in apparent cation affinities are not explained by a shift in the poise of the
E1
E2 balance.
Nevertheless, they do reflect, at least partly, a change in the rates
of limiting steps of its reaction cycle.
 |
EXPERIMENTAL PROCEDURES |
Cell Culture and Membrane Preparation--
HeLa cells expressing
the rat
1,
2*, and
3* enzymes (a generous gift from Dr. J. B
Lingrel) were grown in Dulbecco's modified Eagle's medium
supplemented with 10% newborn calf serum, 100 units of penicillin G,
100 µg/ml streptomycin, and 1 µM ouabain as described previously (9).
NaI-treated microsomal membranes were prepared from the transfected
HeLa cells as described elsewhere (8, 12). Protein concentrations of
the membrane preparations were determined using the Lowry assay as
modified by Markwell et al. (13).
Enzyme Assays--
Na,K-ATPase activity was measured as the
release of 32Pi from [
-32P]ATP
as previously described (14). Unless indicated otherwise, the membranes
were preincubated for 10 min at 37 °C with all reactants added
except ATP. The reaction was initiated by the addition of [
-32P]ATP. Final concentrations for Na,K-ATPase
activity measurements were 100 mM NaCl, 10 mM
KCl, 3 mM MgSO4, 20 mM histidine
(pH 7.4), 5 mM EGTA (pH 7.4), and 5 µM
ouabain (Sigma). To analyze kinetic behavior under various conditions
and unless indicated otherwise, Na,K-ATPase measurements were carried
out using 1 mM ATP as in our earlier studies
(cf. Refs. 9-11), which is reasonably close (
75%) to
saturation. This was done in order to maximize the precision (maximal
percentage of Pi release due to Na,K-ATPase) of the kinetic studies of the relatively low activity transfected cells. A final concentration of 5 mM ouabain was used to determine
base-line hydrolysis activity. Na-ATPase activity was measured at 1 µM ATP as described previously (9), with
varying amounts of added KCl and choline chloride to maintain constant
chloride (40 mM) concentration. Where indicated,
Vmax values shown were derived from activities
measured at 1 mM ATP using values of
K'ATP given in Table
I.
View this table:
[in this window]
[in a new window]
|
Table I
Apparent kinetic constants for substrate affinities of rat 1,
2*, and 3*
Values for apparent kinetic constants were determined using a
noncooperative model of ligand binding as in papers cited below. Values
shown are the mean ± S.D. of the number of experiments shown in
parenthesis.
|
|
For studies of vanadate sensitivity, inorganic orthovanadate (Fisher)
solutions were prepared fresh prior to the experiment and added with
the [
-32P]ATP solution to initiate the reaction at the
indicated concentrations. Values of Na,K-ATPase obtained at various
vanadate concentrations, expressed as percentages of that obtained in
the absence of vanadate, were analyzed by fitting the data to a
one-compartment model using a nonlinear least square analysis of a
general logistic function as described elsewhere (15, 16).
Effects of varying pH on Na-ATPase or Na,K-ATPase were determined as
indicated in the above enzyme assays except using 30 mM
MES1/Tris (pH values of 6.2 and 6.5) or 30 mM Tris/HCl (pH
7.0) instead of histidine.
Phosphoenzyme Determination--
Phosphoenzyme levels were
determined as described earlier (11). Briefly, membranes were
preincubated with ouabain (20 µM ouabain, 0.4 mM MgSO4, and 10 mM
glycylglycine-Tris (pH 7.4)) for 10 min at 37 °C to inhibit
endogenous HeLa Na,K-ATPase. The suspension was then treated with
oligomycin (0.2 mg/ml) for 1 min at room temperature. Phosphorylation
was then carried out in a total volume of 200 µl at 0 °C for
10 s with 100 mM NaCl, 10 mM
glycylglycine-Tris (pH 7.4), 5 mM EGTA (pH 7.4), 1 mM MgSO4, and 1 µM
[
-32P]ATP (specific activity, 10,000-20,000
cpm/pmol). Base-line activity was determined by replacing 100 mM NaCl with 50 mM KCl and 50 mM
choline chloride and phosphorylating the enzyme in the absence of oligomycin.
Formation of K+-occluded Enzyme--
Assays for
K+ dependence of K+-occlusion
(E1 + K+
E2(K)), where E1 is the
K+-free enzyme and E2(K) is the
occluded enzyme, and the rate of deocclusion
(E2(K)
E1 + K+) were measured indirectly as described elsewhere (11)
with the modifications described by Therien and Blostein (17).
At least two different membrane preparations were assayed, and the data
presented are representative of at least three independent experiments.
Each value shown is the mean ± S.D. of triplicate determinations.
 |
RESULTS |
In the experiments described below, the properties of
2* and
3* are described in terms of their similarities or differences relative to the ubiquitous
1 isoform.
Assessment of Differences in the E1/E2
Conformational Equilibrium
Vanadate Sensitivity--
Inorganic orthovanadate is a transition
state analog of inorganic phosphate that binds to P-type ATPases in the
form of the enzyme from which phosphate is released in the
E2 conformation (18). Accordingly, sensitivity
of these enzymes to vanadate inhibition is a measure of the proportion
of enzyme in the E2 conformation during
steady-state catalysis. Thus, for mutants of various P-type pumps,
including plant and yeast proton pumps and the Na,K-ATPase, this
criterion has provided insight into shifts in the
E1/E2 distribution (for
recent examples, see Refs. 19-21). From the present comparative
analysis of the vanadate sensitivity of the highly homologous
1,
2*, and
3* Na,K-ATPase isoforms, it is evident that the
Na,K-ATPase activity of
2* is ~20-fold less sensitive to vanadate
inhibition than
1 (Fig.
1A), suggesting a shift in the
E1/E2 distribution toward E1. In
contrast, no significant difference in vanadate sensitivity of
3*
compared with
1 could be detected. Although the representative
experiment shown in Fig. 1A was carried out at 1 mM ATP and 3 mM MgCl2, similar
results (not shown) were obtained at 3 mM ATP, with 5 mM MgCl2 added to maintain a 2 mM
excess of Mg2+ (IC50 values were 0.80 ± 0.15, 12.1 ± 4.3, and 1.2 ± 0.4 µM for
1,
2*, and
3*, respectively). Fig. 1B shows that similar
results were also obtained when pump turnover was measured in the
absence of K+ (Na-ATPase activity), precluding effects of
vanadate secondary to differences in interactions with
K+.

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 1.
Vanadate sensitivity of Na,K-ATPase and
Na-ATPase activity. ATP hydrolysis at varying vanadate
concentrations was determined as described under "Experimental
Procedures." Representative experiments are shown. A,
effect of vanadate on Na,K-ATPase activity. Data are presented as
percentage of Na,K-ATPase activity (control) measured in the absence of
vanadate. Control activities were as follows: 194.62 ± 3.29, 143.53 ± 2.22, and 49.40 ± 3.14 nmol/(mg × min) for
1, 2*, and 3*, respectively. IC50 values for
vanadate inhibition were as follows: 1, 3.25 ± 0.65 µM; 2*, 114 ± 0.2 µM
(p < 0.005 relative to 1); and 3*, 3.30 ± 0.61 µM. B, effect of vanadate on Na-ATPase
activity. IC50 values for vanadate inhibition were as
follows: 1, 0.24 ± 0.01 µM; 2*, 6.93 ± 2.10 µM (p < 0.005 relative to 1);
and 3*, 0.11 ± 0.01 µM. , 1; , 2*;
, 3*.
|
|
Catalytic Turnover--
Catalytic turnover of the Na,K-ATPase is
estimated as the ratio of Vmax to
EPmax, the latter measured at 0 °C in the
presence of 100 mM NaCl, with K+ omitted and
oligomycin added to trap the enzyme in the
(Na)E1P state (see "Experimental
Procedures"). As shown in Table II, in the presence of K+ (Na,K-ATPase mode), the catalytic
turnover of
2* is ~40% that of
1 as observed previously (9).
The turnover of
3* is also lower (~50% of
1). In contrast,
when the turnover of Na-ATPase is estimated as the product of
Na-ATPase/Na,K-ATPase and
Vmax(Na,K-ATPase)/EPmax, the turnover of
3* is similar (20 mM Na+;
Table II) or even higher (100 mM Na+; not
shown) than that of
1, the former probably reflecting the lower
K'Na for
3*. Turnover of
2* remains
reduced in both the presence and absence of K+.
View this table:
[in this window]
[in a new window]
|
Table II
Catalytic turnover in absence and presence of K+
Na,K-ATPase turnover values were obtained from the ratio of Na,K-ATPase
activity measured at 37 °C in the presence of 100 mM
NaCl, 10 mM KCl, and 1 mM ATP, to a maximal
amount of EP measured at 0 °C in the presence of 100 mM NaCl, 1 µM ATP, and 20 µg/ml oligomycin.
S.D. values of the ratios were obtained from a Monte Carlo simulation
of a joint probability distribution. Na-ATPase/Na,K-ATPase values are
the averages of the ratios of Na-ATPase to Na,K-ATPase of three
separate membrane preparations, where Na-ATPase was carried out at 20 mM NaCl as described under "Experimental Procedures."
Na-ATPase turnover (a × b) was estimated as
the product of the Na,K-ATPase turnover (a) and the
Na-ATPase/Na,K-ATPase ratio (b). Shown are the mean
values ± S.D.
|
|
pH Sensitivity--
The pH sensitivity profile of Na,K-ATPase and
its relevance to the issue of rate-limiting reaction(s) were addressed
in earlier studies of Forbush and Klodos (22). Their experiments showed that the pathway involving deocclusion of K+
(E2(K)
E1) is
partially rate-limiting at acidic pH, whereas the
E1
E1P and
E1P
E2P processes are
more rate-limiting at alkaline and neutral pH, respectively. In the
present study, we compared the pH profiles of the three isoforms over
the pH range of 6.0-8.5. As shown in Fig.
2, the activity of all three isoforms declines as pH is decreased below or increased above the optimal. Compared with
1, the activity of
2* is diminished to a lesser extent at acidic pH and more at alkaline pH, consistent with relatively faster E2(K)
E1 and
slower E1 
E2P transitions and
hence with a preponderance of enzyme in E1
state(s). Although the pH profile of
3* resembles that of
1 at
acidic pH, it decreases more significantly than
1 on the alkaline
side of the optimum, the significance of which is discussed below.

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 2.
pH dependence of Na,K-ATPase activity.
Na,K-ATPase activity was measured in the presence of 100 mM
NaCl, 10 mM KCl, 3 mM MgSO4, 1 mM EGTA with either 30 mM MES (pH 6.5) or 30 mM Tris/HCl (pH 7.0) as described under "Experimental
Procedures." The Na,K-ATPase activities corresponding to 100% were
260.70 ± 0.93, 170.29 ± 2.68, and 192.21 ± 1.87 nmol/(mg × min) for 1, 2*, and 3*, respectively. pH
values indicated were measured at room temperature. Symbols
are as described in legend to Fig. 1.
|
|
Distinct Interactions with Ligands: Comparison of
3* with
1 and
2*
Since the differences in ligand binding affinities of
3* and
1 hold true despite their similar sensitivities to vanadate, it may
be inferred that
3* differs from
1 primarily in its interaction with alkali cation ligands. Nevertheless, certain aspects of
3* kinetic behavior have remained enigmatic and a further comparative analysis of ligand interactions was carried out to explore the mechanistic basis for
3*-specific properties.
Cytoplasmic Na+ Effects and the Role of Li+
as a Na+ Congener--
To determine whether
3* has an
intrinsically lower affinity for Na+, ATP hydrolysis was
measured in the absence of K+ and with the Na+
concentration varied up to 10 mM to favor interactions
primarily with cytoplasmic Na+ activation sites.
Comparisons of
3* and
1 were carried out at pH values of 6.2, 7.4, and 8.0. The results shown in Fig. 3 indicate that large differences in K'Na persist
at all pH values tested, consistent with an intrinsic difference in
apparent Na+ affinity between
1 and
3*. For
3*
compared with
1, respectively, K'Na values
were 0.125 ± 0.036 and 0.552 ± 0.018 mM at pH
6.2, 0.046 ± 0.005 and 0.335 ± 0.046 mM at pH
7.4, and 0.066 ± 0.030 and 0.753 ± 0.372 mM at
pH 8.0 (p < 0.05 at all pH values).

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 3.
Na+ activation kinetics of
1 and 3* at varying
pH. Na-ATPase activity was measured in the presence of 1 µM ATP with varying concentrations of NaCl as indicated.
Data are presented as percentage of maximal Na-ATPase activity
(control) measured at 10 mM NaCl. pH values shown were
measured at room temperature. The data were fit to a noncooperative
three-site model as described by Garay and Garrahan (23);
i.e. v = Vmax/(1 + K'Na/[Na+])3, where
K'Na is the apparent affinity for intracellular
Na+. K'Na values were 0.125 ± 0.036 and 0.552 ± 0.018 mM at pH 6.2, 0.046 ± 0.005 and 0.335 ± 0.046 mM at pH 7.4, and 0.066 ± 0.030 and 0.753 ± 0.372 mM at pH 8.0 for 3*
compared with 1 (p < 0.05 at all pH values).
Symbols are as described in the legend to Fig. 1.
|
|
In the case of
1, Li+ can act as a congener of
cytoplasmic Na+ as well as extracellular K+
(24, 25). The experiment shown in Fig. 4
was carried out to test whether this holds true for
2* and
3*.
The results show that Li+ can replace Na+ and
stimulate ATP hydrolysis for both the
1 and
2* enzymes but not in
the case of
3*. This finding underscores the large difference in
cation selectivity of
3* compared with
1 or
2*.

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 4.
Li+-stimulated ATP
hydrolysis. ATP hydrolysis at varying LiCl concentrations was
determined at 1 µM ATP as described under "Experimental
Procedures." The data are expressed as percentage of maximal
Li+-ATPase activity. Symbols are as described in
the legend to Fig. 1.
|
|
Interactions with Extracellular K+ and
Li+--
In an earlier study, we showed that
K+ stimulates Na-ATPase activity of
2* at micromolar ATP
concentration but inhibits both
1 and
3*. The explanation that
E2(K)
E1 of
2* is
faster relative to other reactions of the cycle was substantiated by
measurements of the E2(K)
E1 rate of
1 and
2* (9). With
Li+ replacing K+, Na-ATPase activity of all
three isoforms was stimulated in the order
2*
3*
1,
consistent with Li+ acting as a congener of K+
and with a known faster deocclusion compared with K+ (26).
Nevertheless, the observation that K+ inhibits
1 and
3* to similar extents whereas Li+ stimulates
2* and
3* but not
1 suggests distinct properties of
3* with respect
to interaction with extracellular alkali cations and/or the rate of
another reaction step. Therefore, to gain insight into the basis for
these isoform-distinct effects of Li+ and K+,
we compared
3* and
1 with respect to rates of K+
occlusion and deocclusion as described below.
K0.5 for K+ Occlusion--
The
K+ dependence for formation of the K+-occluded
enzyme, E1 + K+
E2(K), was measured indirectly as the decrease
in phosphoenzyme (E32P formed by phosphorylation
with [
-32P]ATP) following equilibration of the enzyme
in the absence or presence of varying concentrations of K+
as described previously (9, 27)). The decrease in
E32P resulting from preincubation with
K+ is a measure of the amount of
E2(K+). Fig.
5 shows a representative
K+-occlusion profile of
3* and
1. Using the simple
model Bmax[S]/(K0.5 + [S]) to describe K+ occlusion, where
Bmax is the maximally bound enzyme
(28), the values of the equilibrium constant for
K+ occlusion, K0.5, were 0.031 ± 0.007 and 0.046 ± 0.008 mM for
1 and
3*,
respectively, and, therefore, not significantly different (p > 0.5). (This contrasts with the
3-fold increase
in K0.5 for
2* compared with
1 (11).)
Maximum formation of E2(K) with both
1 and
3* was observed at 1 mM KCl as shown previously for
1
(11).

View larger version (11K):
[in this window]
[in a new window]
|
Fig. 5.
Occlusion of K+ at 0 °C.
Formation of EP at various concentrations of KCl was
determined as described under "Experimental Procedures." Data are
presented as percentage of maximal E32P, which
is the difference of E32P formed in the absence
of K+ minus E32P formed in the
presence of K+. Values of maximal
E32P were (pmol/mg) 18.66 ± 0.76, and
14.47 ± 0.34, for 1 and 3*, respectively. The results were
fitted to a simple model of K+ binding
(Bmax
[K+]/(K0.5 + [K+])).
Symbols are as described in the legend to Fig. 1.
|
|
E2(K)
E1--
The rate of the
E2(K)
E1 deocclusion
process was estimated indirectly by measuring the rate of
E1 formation from E2(K)
as described previously (11, 27). The results of the representative experiment shown in Fig. 6 indicate that
the K+ deocclusion rate for
3*, similar to that
determined earlier for
2* (11), is faster than that of
1. The
fold increase obtained in three similar independent experiments was
3.4 ± 0.5. Since K0.5 for K+
occlusion is similar for
1 and
3*, the rate of
E1 + K+ 
E2(K) must also be 3-fold faster for
3*. The
implication of the faster deocclusion vis-à-vis the effects of
K+ on Na-ATPase at micromolar ATP concentration is
considered below.

View larger version (11K):
[in this window]
[in a new window]
|
Fig. 6.
Rate of formation of
E1 from E2(K)
at 10 °C. Formation of E1 was determined
at the indicated times following occlusion of K+ as
described under "Experimental Procedures." Data are presented as
percentage of control E32P, which is the
difference ((E32P formed in the absence of
K+ at 0 °C) minus (E32P formed in
the presence of 4 mM K+ at
10 °C))/((E32P formed in the absence of
K+ at 0 °C) minus (E32P formed in
the presence of 4 mM K+ at 0 °C).
Symbols are as described in legend to Fig. 1.
|
|
 |
DISCUSSION |
In the present study, we have extended earlier comparisons of the
rat
1,
2*, and
3* isoforms expressed in the same (HeLa) cell
environment (8, 10) to gain insight into the mechanistic basis for
their distinct behavior. The following discussion focuses on the
properties of
2* and
3* as they relate to those of the ubiquitous
1 isoform.
The
2 Isoform--
From a comparison with the ubiquitous
1
isoform, it is now clear that the main distinguishing property of the
2* isoform is its poise in conformational equilibrium in favor of
E1 forms. There are several observations in
support of this conclusion. Thus, earlier studies showed that the
E2(K)
E1 transition
associated with K+-deocclusion is faster for
2* than for
1 and that the apparent affinity for low affinity ATP binding is
2-3 times higher for
2* compared with
1 (8-10). Further
supportive evidence is the present finding of a ~20-fold increase in
IC50 for vanadate inhibition of
2* compared with either
1 or
3*, indicating a shift in equilibrium away from the
E2 state(s). Another point of evidence is the
2*-distinct pH profile. As already discussed, the smaller decrease
in activity of
2* at acidic pH and greater decrease at alkaline pH
also implicate shifts of rates of partial reactions in favor of
E1 form(s).
It is noteworthy that the distinctive behavior of
2* vis-à-vis
1 is remarkably similar to the behavior of
1 mutants obtained by
deletion of the first 32 residues from the amino terminus and by a
Glu233
Lys substitution in the cytoplasmic loop between
M2 and M3. Generally similar differences from
1 were obtained in the
aforementioned properties for these mutants, including faster
E2(K)
E1, slower catalytic turnover, lower K'ATP for low affinity
ATP binding, and decreased sensitivity of Na,K-ATPase activity to
vanadate inhibition, all leading to the conclusion that these are
mutants with the E1
E2 equilibrium shifted toward
E1 (21, 29). Current studies aimed to identify
distinct cytoplasmic regions of
2* that underlie its altered
conformational transitions are under way.
The
3 Isoform--
A mechanistic explanation for the distinct
kinetic properties of
3* is more complex. As shown previously,
differences in K+/Na+ antagonism at cytoplasmic
Na+ activation sites underlie much of the variability in
K'Na noted in studies with intact cells
comprising high intracellular K+ versus studies
with membrane fragments analyzed at relatively low K+
concentration (see Ref. 30 and Table I). When the complexity of
competing effects of Na+ and K+ is eliminated
by analyzing the reaction cycle in the absence of K+, and
under conditions of enzyme turnover with Na+ varied up to
10 mM to limit its interaction to primarily
cytoplasm-facing sites, a markedly lower apparent affinity of
3* for
Na+ is observed (Fig. 3). This behavior supports the notion
of
3-distinct cation ligation. It is noteworthy that an earlier
analysis of a series of
1/
3* chimeras expressed in HeLa cells
failed to identify a region clearly responsible for the differences in
apparent Na+ affinity between the two isoforms (31). This
is not surprising in view of the present experiments, which indicate
that a difference in cation binding or selectivity is not the sole
determinant of
3- versus
1-distinct apparent
affinities for Na+ and K+ activation as
discussed further below. The remarkable ability of
3* to utilize
Na+ over Li+ focuses on its distinctive cation
interactions with cytoplasmic Na+ and should be an
invaluable criterion for identification of specific residues comprising
either the selectivity filter, gate, or Na+ binding pocket
of the catalytic subunit.
Despite the evidence of an intrinsic difference in
K'Na of
3* compared with
1 and
2*,
several observations suggest that the apparent Na+ and
K+ affinities are affected, in an isoform-specific manner,
by the rates of reactions associated with Na+ and
K+ translocation. Thus, if one considers the sequence
E1 + Na+ + ATP
Na·E1P
E2P + Na+, a decrease in the rate of E1P
formation from E1 or a higher rate of the
subsequent E1P
E2P
reaction should effectively increase K'Na. The
greater decline in activity of
3* at alkaline pH suggests greater
rate limitation of the former reaction in the case of
3*
(cf. Ref. 22). Furthermore, the conclusion that the
phosphorylation reaction also contributes to rate limitation under
Vmax conditions at physiological pH is supported
by the lower turnover of
3* compared with
1 under near
Vmax conditions in the presence of both
Na+ and K+ (Na,K-ATPase activity).
On the other hand, compared with
1, the
Na·E1P
E2P
transition is probably intrinsically faster for
3* for the following reason. Inhibition of Na-ATPase by low concentrations of K+
is observed at micromolar ATP concentration with both the
1 and
3*, but not the
2*, isoform (9). For
1, this behavior is
thought to be a consequence of the rate-limiting
E2(K)
E1 process,
which at low ATP is slower than E2
E1 in the absence of K+. This holds
true despite the evidence for an intrinsically faster rate of formation
of E1 from E2(K) noted in
this study.
The most straightforward explanation for the foregoing paradox is that
reaction steps comprising the conformational transition of
phosphoenzyme that lead to release of three Na+ ions to the
extracellular milieu (Na3E1P
E2P + 3Na+) as well as the K+
deocclusion process (E2(K)
E1 + K+) are proportionately faster
for
3*, with the result that the K+ deocclusion process
is similarly rate-limiting at low ATP concentration, for
3* as for
1. Relevant to the presumably faster
Na3E1P
E2P + 3Na+ for
3* is the
observation that the human
3 enzyme, expressed in Xenopus
oocytes, shows almost no voltage dependence of pump current over the
range of
150 to +50 mV in the presence of extracellular Na+ and K+ (32). (The greater voltage
dependence of
2 observed in that study is consistent with more rate
limitation of this step as well as with the preference of this isoform
for the E1 conformation.) This led these authors to suggest
that there is an isoform-specific difference in the backward rate
constant for the Na+ release step. Accordingly, less rate
limitation of the Na3·E1P
E2P + 3Na+ process would be
consistent with the loss of voltage dependence of the
3-catalyzed
reaction in the presence of extracellular Na+. Decreased
voltage dependence may, in turn, reflect either the decreased affinity
of
3 for allosteric Na+ inhibition of pump flux (33) or
a decrease in Na+ antagonism of
K+ext binding (see Ref. 34). Thus, in either case, an increase in the relative rate of the forward E1P
E2P process of the Na+ and K+
reaction cycle is observed. Studies are currently under way to compare
the voltage dependence of pump current in rat
isoform-transfected HeLa cells.
With the human enzyme, little, if any difference in
K'K of
3 was observed except under conditions
of extreme hyperpolarization in presence of
Na+ext (32); in Sf-9 cells, the apparent
affinity for K+ was somewhat lower for
3 compared with
1 (6). It is unlikely that the difference in
K'K seen with the rat
3* enzyme is due to the
mutation to ouabain resistance, since the difference persists when
ouabain-resistant rat kidney
1 and rat axolemma (~70%
3) enzymes are compared (30). More likely, the discordant findings suggest
that the isoforms do not differ in their intrinsic
K+ binding/occlusion but rather in the relative rates of
reaction(s) associated with K+-activated dephosphorylation
of E2P. Accordingly, an increase in the rate of
the proceeding K+ deocclusion process
[E2(K)
E1] or
preceding E1P
E2P
transition would effectively decrease and increase, respectively, the
apparent affinity for K+. Although the present study
indicates that these two processes are faster for
3, the relative
magnitudes of the increases probably differ when the enzyme is analyzed
in both a different membrane environment and at a different temperature
(Xenopus membranes assayed at ambient temperature (32)
versus HeLa membranes assayed at 37 °C).
In conclusion, the main distinguishing feature of
2* is its shift in
conformational equilibrium toward E1. On the
other hand, the
3* isoform resembles
1 in its conformational
equilibrium. Its lower apparent affinity for
Na+cyt is due, in large part, to intrinsic
differences in cation binding and, to some extent, to differences in
rates of limiting forward and reverse steps in the catalytic cycle. The
higher apparent affinity of
3 for K+ext is
probably secondary to differences in the rates of reactions preceding
and subsequent to K+-activated dephosphorylation.
Although the relationship between the kinetics of the individual
isoforms and their distinct physiological roles in various tissues
remains elusive, a few clues are notable. In neuronal tissue, the lower
affinity of
3 for Na+cyt suggests that
3
may only be activated when the Na+cyt
concentration reaches its maximum following repeated firing, possibly
acting as a "spare pump" to restore membrane potential (8, 10). It
is also plausible that the higher ATP affinity of
3 compared with
the ubiquitous
1 allows it to function at the low ATP concentrations
found near the membrane (7). This
3-distinct property (
2 as well)
is reminiscent of the shift in ATP affinity of
1 conferred by
interaction with the
subunit in the renal outer medulla, which may
allow the pump to function more efficiently under the near anoxic
conditions found in this portion of the kidney (35). It is also
plausible that the higher apparent ATP affinity of
2 and the
maintenance of activity under acidic and metabolically depleted
conditions are advantageous for skeletal muscle tissue during
exercise. In fact, it has been shown that in both the rat (36) and
human (37) exercise induces the translocation of
2
1 pumps from an intracellular pool to the plasma membrane of skeletal muscle. That the
presence of
3 in neonatal rat cardiac myocytes, with its low
Na+ affinity, would be particularly effective in raising
cytosolic Ca2+ is supported by the coincidence of the
switch from
3 to
2 to the shortening of the action potential
duration in rat heart during ontogeny (38-40). Although studies with
cardiac myocytes in which
1 is down-regulated implicate
1 as
having a major role in regulation of cardiac Ca2+ (41), a
specific role of
2 in Ca2+ signaling during heart
contraction was clearly evidenced in studies of genetically reduced
levels of
2 in the heart (42). The information provided by the
present study taken together with earlier studies of isoform-specific
kinetics represents an important step toward a better understanding of
the basis for their distinct roles in native tissues.
 |
ACKNOWLEDGEMENTS |
We thank Drs. E. Jewell and J. B Lingrel for
the rat isoform-transfected cells and Dr. R. Daniel Peluffo for helpful
comments on the manuscript. The excellent technical assistance of
Rosemarie Scanzano is gratefully acknowledged.
 |
FOOTNOTES |
*
This work was supported by grants from the Medical Research
Council of Canada and Quebec Heart and Stroke Foundation (to R. B.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Supported by a predoctoral traineeship from the Heart and Stroke
Foundation of Canada.
Published, JBC Papers in Press, June 26, 2001, DOI 10.1074/jbc.M103720200
§
To whom correspondence should be addressed: Montreal General
Hospital, 1650 Cedar Ave., Montreal, Quebec H3G 1A4, Canada. Tel.:
514-937-6011 (ext. 4501); Fax: 514-934-8332.
 |
ABBREVIATIONS |
The abbreviations used are:
MES, 4-morpholineethanesulfonic acid;
EP, the
phosphoenzyme form of the Na,K-ATPase;
Na+cyt, intracellular Na+;
K+ext, extracellular K+.
 |
REFERENCES |
| 1.
|
Sweadner, K. J.
(1989)
Biochim. Biophys. Acta
988,
185-220
|
| 2.
|
Lingrel, J. B,
and Kuntzweiler, T.
(1994)
J. Biol. Chem.
269,
19659-19662
|
| 3.
|
Mercer, R. W.,
Biemesderfer, D.,
Bliss, D. P., Jr.,
Collins, J. H.,
and Forbush, B., III
(1993)
J. Cell Biol.
121,
579-586
|
| 4.
|
Therien, A. G.,
and Blostein, R.
(2000)
Am. J. Physiol.
279,
C541-C566
|
| 5.
|
Woo, A. L.,
James, P. F.,
and Lingrel, J. B
(1999)
J. Membr. Biol.
169,
39-44
|
| 6.
|
Woo, A. L.,
James, P. F.,
and Lingrel, J. B
(2000)
J. Biol. Chem.
275,
20693-20699
|
| 7.
|
Blanco, G.,
and Mercer, R. W.
(1998)
Am. J. Physiol.
275,
F633-F650
|
| 8.
|
Jewell, E. A.,
and Lingrel, J. B
(1991)
J. Biol. Chem.
266,
16925-16930
|
| 9.
|
Daly, S. E.,
Lane, L. K.,
and Blostein, R.
(1994)
J. Biol. Chem.
269,
23944-23948
|
| 10.
|
Munzer, J. S.,
Daly, S. E.,
Jewell-Motz, E. A.,
Lingrel, J. B,
and Blostein, R.
(1994)
J. Biol. Chem.
269,
16668-16676
|
| 11.
|
Daly, S. E.,
Lane, L. K.,
and Blostein, R.
(1996)
J. Biol. Chem.
271,
23683-23689
|
| 12.
|
Lane, L. K.,
Feldmann, J. M.,
Flarsheim, C. E.,
and Rybczynski, C. L.
(1993)
J. Biol. Chem.
268,
17930-17934
|
| 13.
|
Markwell, M. A.,
Haas, S. M.,
Tolbert, N. E.,
and Bieber, L. L.
(1981)
Methods Enzymol.
72,
296-303
|
| 14.
|
Blostein, R.
(1988)
Methods Enzymol.
156,
171-178
|
| 15.
|
DeLean, A.,
Munson, P. J.,
and Rodbard, D.
(1978)
Am. J. Physiol.
235,
E97-E102
|
| 16.
|
Berrebi-Bertrand, I.,
Maixent, J. M.,
Christe, G.,
and Lelievre, L. G.
(1990)
Biochim. Biophys. Acta
1021,
148-156
|
| 17.
|
Therien, A. G.,
and Blostein, R.
(1999)
Am. J. Physiol.
277,
C891-C898
|
| 18.
|
Cantley, L. C., Jr.,
Cantley, L. G.,
and Josephson, L.
(1978)
J. Biol. Chem.
253,
7361-7368
|
| 19.
|
Ambesi, A.,
Miranda, M.,
Allen, K. E.,
and Slayman, C. W.
(2000)
J. Biol. Chem.
275,
20545-20550
|
| 20.
|
Buch-Pedersen, M. J.,
Venema, K.,
Serrano, R.,
and Palmgren, M. G.
(2000)
J. Biol. Chem.
275,
39167-39173
|
| 21.
|
Boxenbaum, N.,
Daly, S. E.,
Javaid, Z. Z.,
Lane, L. K.,
and Blostein, R.
(1998)
J. Biol. Chem.
273,
23086-23092
|
| 22.
|
Forbush, B., III,
and Klodos, I.
(1991)
Soc. Gen. Physiol. Ser.
46,
210-225
|
| 23.
|
Garay, R. P.,
and Garrahan, P. J.
(1973)
J. Physiol. (Lond.)
231,
297-325
|
| 24.
|
Blostein, R.,
Pershadsingh, H. A.,
Drapeau, P.,
and Chu, L.
(1979)
in
Na, K-ATPase: Structure and Kinetics
(Skou, J. C.
, and Norby, J. G., eds)
, p. 233, Academic Press, Inc., New York
|
| 25.
|
Dunham, P. B.,
and Senyk, O.
(1977)
Proc. Natl. Acad. Sci. U. S. A.
74,
3099-3103
|
| 26.
|
Post, R. L.,
Hegyvary, C.,
and Kume, S.
(1972)
J. Biol. Chem.
247,
6530-6540
|
| 27.
|
Therien, A. G.,
and Blostein, R.
(1999)
Am. J. Physiol.
277,
C891-C898
|
| 28.
|
Shani, M.,
Goldschleger, R.,
and Karlish, S. J.
(1987)
Biochim. Biophys. Acta
904,
13-21
|
| 29.
|
Daly, S. E.,
Blostein, R.,
and Lane, L. K.
(1997)
J. Biol. Chem.
272,
6341-6347
|
| 30.
|
Therien, A. G.,
Nestor, N. B.,
Ball, W. J.,
and Blostein, R.
(1996)
J. Biol. Chem.
271,
7104-7112
|
| 31.
|
Jewell, E. A.,
and Lingrel, J. B
(1992)
Ann. N. Y. Acad. Sci.
671,
120-132
|
| 32.
|
Crambert, G.,
Hasler, U.,
Beggah, A. T., Yu, C.,
Modyanov, N. N.,
Horisberger, J. D.,
Lelievre, L.,
and Geering, K.
(2000)
J. Biol. Chem.
275,
1976-1986
|
| 33.
|
Balshaw, D. M.,
Millette, L. A.,
Tepperman, K.,
and Wallick, E. T.
(2000)
Biophys. J.
79,
853-862
|
| 34.
|
Sachs, J. R.
(1977)
J. Physiol.
264,
449-470
|
| 35.
|
Therien, A. G.,
Karlish, S. J.,
and Blostein, R.
(1999)
J. Biol. Chem.
274,
12252-12256
|
| 36.
|
Tsakiridis, T.,
Wong, P. P.,
Liu, Z.,
Rodgers, C. D.,
Vranic, M.,
and Klip, A.
(1996)
J. Appl. Physiol.
80,
699-705
|
| 37.
|
Juel, C.,
Nielsen, J. J.,
and Bangsbo, J.
(2000)
Am. J. Physiol.
278,
R1107-R1110
|
| 38.
|
Lingrel, J. B,
Orlowski, J.,
Shull, M. M.,
and Price, E. M.
(1990)
Prog. Nucleic Acids Res. Mol. Biol.
38,
37-89
|
| 39.
|
Lucchesi, P. A.,
and Sweadner, K. J.
(1991)
J. Biol. Chem.
266,
9327-9331
|
| 40.
|
Berrebi-Bertrand, I.,
and Maixent, J. M.
(1994)
FEBS Lett.
348,
55-60
|
| 41.
|
Komehani, P.,
Askari, A.,
Liu, J.,
Xie, Z.,
and Askari, F. K.
(2001)
Am. J. Physiol.
280,
H1415-H1421
|
| 42.
|
James, P. F.,
Grupp, I. L.,
Grupp, G.,
Woo, A. L.,
Askew, G. R.,
Croyle, M. L.,
Walsh, R. A.,
and Lingrel, J. B
(1999)
Mol. Cell
3,
555-63
|
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Edwards and T. L. Pallone
Ouabain modulation of cellular calcium stores and signaling
Am J Physiol Renal Physiol,
November 1, 2007;
293(5):
F1518 - F1532.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Edwards and T. L. Pallone
Modification of cytosolic calcium signaling by subplasmalemmal microdomains
Am J Physiol Renal Physiol,
June 1, 2007;
292(6):
F1827 - F1845.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. E. Moseley, M. T. Williams, T. L. Schaefer, C. S. Bohanan, J. C. Neumann, M. M. Behbehani, C. V. Vorhees, and J. B Lingrel
Deficiency in Na,K-ATPase {alpha} Isoform Genes Alters Spatial Learning, Motor Activity, and Anxiety in Mice
J. Neurosci.,
January 17, 2007;
27(3):
616 - 626.
[Abstract]
[Full Text]
[PDF]
|
 |
|